Home2196 • HKG
Follow
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Previous close
$11.50
Day range
$11.34 - $11.54
Year range
$11.32 - $23.80
Market cap
58.53B HKD
Avg Volume
3.68M
P/E ratio
11.83
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 10.70B | -13.22% |
Operating expense | 4.97B | -6.82% |
Net income | 103.20M | -92.03% |
Net profit margin | 0.96 | -90.86% |
Earnings per share | — | — |
EBITDA | 453.50M | -61.56% |
Effective tax rate | 965.06% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 15.58B | -9.25% |
Total assets | 113.47B | 5.88% |
Total liabilities | 56.85B | 7.16% |
Total equity | 56.62B | — |
Shares outstanding | 2.67B | — |
Price to book | 0.67 | — |
Return on assets | -0.47% | — |
Return on capital | -0.58% | — |
Cash Flow
Net change in cash
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 103.20M | -92.03% |
Cash from operations | 952.58M | -11.29% |
Cash from investing | -535.00M | -486.22% |
Cash from financing | -939.67M | -72.55% |
Net change in cash | -579.77M | -221.60% |
Free cash flow | 2.67B | -12.67% |
About
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
CEO
Founded
1994
Website
Employees
40,370